The 20 Best Muscle Invasive Bladder Cancer Doctors Near Me in Bronx, NY

James McKiernan, MD, is the John K. Lattimer Professor of Urology and CEO of ColumbiaDoctors. He is also Senior Vice Dean for Clinical Affairs for Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer. Dr. Mckiernan is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Nephrectomy. Dr. Mckiernan is board certified in Urology. Dr. Mckiernan is currently accepting new patients.

Reza Mehrazin is a Urologist practicing medicine in New York, New York. Dr. Mehrazin is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy. Dr. Mehrazin is currently accepting new patients.

Matthew Galsky is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Galsky is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Orchiectomy, and Nephrectomy. Dr. Galsky is currently accepting new patients.

John Sfakianos is a Urologist practicing medicine in Astoria, New York. Dr. Sfakianos is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Sfakianos is currently accepting new patients.

Alexandre Zlotta practices practicing medicine in Canada. Mr. Zlotta is rated as an Elite expert by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Prostatectomy.

Bernard Bochner is a Urologist practicing medicine in New York, New York. Dr. Bochner is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy. Dr. Bochner is currently accepting new patients.

Harry Herr is a Urologist practicing medicine in New York, New York. Dr. Herr is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Endoscopy. Dr. Herr is currently accepting new patients.

Dean Bajorin is an Oncologist practicing medicine in New York, New York. Dr. Bajorin is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Orchiectomy, and Nephrectomy. Dr. Bajorin is currently accepting new patients.

Guido Dalbagni is a Urologist practicing medicine in New York, New York. Dr. Dalbagni is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy.

Girish Kulkarni is a Urologist practicing medicine in New York, New York. Dr. Kulkarni is rated as an Elite provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Cystectomy, and Prostatectomy.

Alexander I. Sankin, MD, is Professor, Urology at Montefiore Einstein. His clinical specialty is surgical approaches to treating urological malignancies, including prostate, testicular, renal and bladder cancer. Dr. Sankin is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Ureteroscopy.

Benjamin A. Gartrell, MD, is Director, Genitourinary Malignancy Program at Montefiore and an Assistant Professor of Oncology and Urology at our Albert Einstein College of Medicine. Since joining the Montefiore team in 2012, his expertise has been in treating genitourinary malignancies including prostate cancer, bladder cancer, renal cell cancer, and testicular cancer. He is also very active in translating science findings in collaboration with research colleagues at Einstein. In 2000, Dr. Gartrell received his Bachelor of Arts in Chemistry at the College of Wooster in Ohio. Following this, he attended the Northwestern University?s Feinberg School of Medicine, in Chicago, Illinois, where he received his Doctor of Medicine in 2005. His postgraduate training began in 2005 with an internship and residency in Internal Medicine at Case Western Reserve University, which he completed in 2008. He then completed a fellowship in Hematology/Oncology at Mount Sinai School of Medicine in 2012 and became Chief Fellow from 2010-2011. With a vast range of research interests, Dr. Gartrell focuses on translational research evaluating the significance of a novel immune checkpoint molecule in bladder cancer, evaluating the role of the autonomic nervous system in?prostate cancer, toxicities associated with anticancer therapies, and the impact of bone metastasis on patients with prostate cancer. His work has been published in a number of peer-reviewed journals, including the Journal of Clinical Oncology, Urologic Oncology, and European Urology. Dr. Gartrell also participates in community outreach to promote Prostate Cancer Awareness. Dr. Gartrell is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Nephrectomy, and Prostatectomy.

Mitchell Laks is a Radiologist practicing medicine in Bronx, New York. Dr. Laks is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Splenomegaly, and Progressive Familial Intrahepatic Cholestasis Type 3.

Dr. Kara L. Watts, Associate Professor of Urology, joined the urology faculty at Montefiore in 2016. She completed a fellowship in Quality and Performance Improvement in Healthcare and an extended observership in focal ablation for prostate cancer in the UK. She serves as the Director of Quality Assurance and Improvement for the Department of Urology and leads the prostate cancer screening program. Dr. Watts is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Kidney Stones, Muscle Invasive Bladder Cancer, Vasectomy, and Ureteroscopy.

Dr. Hiram Shaish graduated from Dartmouth College and received his M.D. from Mount Sinai School of Medicine. He is currently Assistant Professor of Radiology at Columbia University Medical Center (CUMC). Dr. Shaish completed his residency at Westchester Medical Center in Diagnostic Radiology and fellowship at New York University. He is a member of the Society of Abdominal Radiology. Dr. Shaish's research interests include Prostate MR imaging and cystic renal lesions. Dr. Shaish is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 29 other conditions, according to our data. His clinical expertise encompasses Pleurisy, Pleural Effusion, Muscle Invasive Bladder Cancer, Nasal Flaring, and Ureteroscopy. Dr. Shaish is board certified in Diagnostic Radiology. Dr. Shaish is currently accepting new patients.

Dr. Weiner is an Associate Professor of Medicine at Columbia University Medical Center (CUMC). He is the Medical Director of the Hypertrophic Cardiomyopathy Center at CUMC where he specializes in the diagnosis and management of patients with hypertrophic cardiomyopathy. The Hypertrophic Cardiomyopathy Center utilizes all the resources at the medical center to provide comprehensive care including advanced cardiac imaging, invasive septal reduction therapies (septal myectomy or alcohol septal ablation) when indicated, and cardiogenetics.Dr. Weiner also has expertise in coronary artery disease, valvular heart disease, pericardial disease, and other cardiomyopathies. Additionally, he sees patients for cardiovascular risk assessment with particular attention devoted to high blood pressure control, cholesterol management, and optimization of lifestyle considerations.In addition to his clinical practice, Dr. Weiner is an Attending physician at Columbia University Medical Center's Cardiovascular Ultrasound laboratory where he performs and interprets stress echocardiograms, transesophageal echocardiograms, and transthoracic echocardiograms.His current research focuses on hypetrophic cardiomyopathy clinical outcomes. Dr. Weiner was the Associate Director for the Cardiovascular Disease Fellowship at CUMC from 2010 - 2016. He is a key faculty member for Columbia University College of Physicians and Surgeons' Cardiovascular Disease course, and was awarded the prestigious Ewig Clinical Scholar Award in 2014 for recognition of his efforts and skills in teaching at the medical school. He also provides Physician Leadership in Clinical Cardiology for the Columbia Heart Source program.Dr. Weiner received his undergraduate degree from Cornell University (with Distinction). He received his MD from Mount Sinai School of Medicine (as a member of the Alpha Omega Alpha Medical Honor Society). He completed his internship and residency in Internal Medicine at NewYork-Presbyterian Hospital/Columbia University Medical Center. He then was selected to be Chief Medical Resident at NewYork-Presbyterian Hospital/Columbia. Following his Chief Medicine Residency, Dr. Weiner completed his fellowship in Cardiovascular Disease at NewYork-Presbyterian Hospital/Columbia, and was selected to be a Chief Fellow during the final year of fellowship training. Dr. Weiner also completed an Advanced Fellowship in Echocardiography at NewYork-Presbyterian Hospital/Columbia. Dr. Weiner is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Hypertrophic Cardiomyopathy (HCM), Angina, Cardiomyopathy, Non-Muscle Invasive Bladder Cancer, and Heart Bypass Surgery. Dr. Weiner is board certified in Internal Medicine and Cardiovascular Disease. Dr. Weiner is currently accepting new patients.

Guarionex Decastro is a Urologist practicing medicine in New York, New York. Dr. Decastro is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Decastro is currently accepting new patients.

"Christopher B. Anderson, MD, Associate Professor of Urology at CUMC, joined the Department of Urology in September 2015. He specializes in cancers of the bladder, prostate, kidney, testis and penis and performs both open and robotic surgeries. Dr. Anderson completed his medical degree from Northwestern University, completed his urology residency at Vanderbilt University, and then spent two years at Memorial Sloan Kettering Cancer Center as a fellow in urologic oncology. Following his residency, Dr. Anderson completed a urologic oncology fellowship at Memorial Sloan Kettering Cancer Center and obtained a Master of Public Health degree from Harvard University.Dr. Anderson's research interests include factors that influence the quality of surgery, access to care for patients with bladder cancer, outcomes after robotic prostatectomy, and active surveillance strategies for men with prostate cancer. Dr. Anderson has published several peer-reviewed articles and was recognized as ""Best Reviewer"" in 2014 by The Journal of Urology and in 2016 by Cancer.Dr. Anderson has clinical expertise in robotic prostatectomy for the treatment of prostate cancer, radical cystectomy with orthotopic neobladder for patients with bladder cancer, and partial nephrectomy for the treatment of kidney tumors. He also specializes in the multidisciplinary management of men with testicular cancer, including the use of primary and post-chemotherapy retroperitoneal lymph node dissection. He is currently the site leader for several clinical trials investigating the use of immunotherapy in patients with invasive and non-invasive bladder cancer.". Dr. Anderson is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Reconstructive Urology Surgery, and Nephrectomy. Dr. Anderson is board certified in Urology. Dr. Anderson is currently accepting new patients.

Lee Richstone, MD is the Chairman of Urology and Director of Urology Services for the Western Region. He is also Director of Laparoscopic and Robotic Surgery at Lenox Hill Hospital and System Vice Chairman for Education for Northwell Health Urology. Dr. Richstone is Professor of Urology at The Hofstra-Northwell School of Medicine. Dr. Richstone completed medical school at the Cornell University Medical College in New York City. There he won early acceptance into Alpha Omega Alpha (AOA), the prestigious national medical honor society. He pursued his urologic training and chief residency at New York Presbyterian (Weill-Cornell) and Memorial Sloan Kettering hospitals. Dr. Richstone completed his fellowship training in urologic laparoscopic and robotic surgery and joined the North Shore Long Island Jewish Health System in 2007 as Director of Laparoscopic and Robotic Surgery. He then served as Chief of Urology for the North Shore University Hospital, then Chief of Urology at the Long Island Jewish Medical Center, before assuming the role of Chairman of Urology at Lenox Hill Hospital in Manhattan. Dr. Richstone is an internationally recognized urologic surgeon who has helped pioneer laparoscopic and robotic surgery for cancer of the prostate, kidney and bladder, as well as for various forms of urinary obstructions. He has over 90 peer-reviewed publications in leading national and international journals including The Journal of Urology, Urology, The British Journal of Urology, The Journal of Endourology, Cancer, and Cell.Dr. Richstone is a robotic surgery specialist having performed well over 1000 operations. This includes surgeries for prostate, kidney and bladder cancer and complex neobladder reconstructions completely robotically. His focus is on preserving urinary continence and sexual function. Dr. Richstone has also pioneered Laparoendoscopic Single Site Surgery (LESS), where entire laparoscopic operations are performed only through the belly button. Dr. Richstone is one of only a few surgeons in the United States to have performed single site partial nephrectomy and prostatectomy.Dr. Richstone is a member of the Society of Urologic Oncology (SUO), the America Urological Association (AUA), and the Endourological Society (EUS). Dr. Richstone is the recipient of numerous honors and awards, including acceptance into Alpha Omega Alpha (AOA), the E. Darracott Vaughan Prize for Excellence in Urology (2000), The Ferdinand C. Valentine Urology Essay Prize (First Place, 2005), The American Urological Association-Ambrose Reed Socioeconomic Essay Contest (First Place, 2005), and the Weill-Cornell Distinguished House Officer Award (2005). Dr. Richstone was awarded the Stryker and Nagamatsu Fellowship (2007), and won first prize at the Endourology Society Fellowship Paper Award the same year. Dr. Richstone won first prize at the AUA Research Foundation for Outstanding Research awarded at the 2010 AUA National Meeting in San Francisco. Dr. Richstone is rated as a Distinguished provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Richstone is board certified in American Board Of Urology.

John Della is a Radiologist practicing medicine in Bronx, New York. Dr. Della is rated as an Advanced provider by MediFind in the treatment of Muscle Invasive Bladder Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Tenosynovitis, Lung Nodules, and Chronic Cough.